Reports for APOTEX INC

Company Name

APOTEX INC

Totals

Shortage reports

3034

Actual shortage: 241 (8%)
Anticipated shortage: 18 (1%)
Avoided shortage: 9 (0%)
Resolved: 2766 (91%)

Discontinuation Reports

356

To be discontinued: 22 (6%)
Discontinued: 334 (94%)
Reversed: 0 (0%)

Late reports

142 (4%)

Overdue reports

30 (11%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-ABACAVIR-LAMIVUDINE 600MG 300MG TABLET Resolved 2019-08-21 2020-01-27 92016
APO-DESVENLAFAXINE 50MG TABLET (EXTENDED-RELEASE) Resolved 2019-08-21 2019-09-16 92019
APO-DILTIAZ CD 180MG CAPSULE (CONTROLLED-DELIVERY) Resolved 2019-08-21 2019-10-15 92022
APO-METFORMIN ER 1000MG TABLET (EXTENDED-RELEASE) Resolved 2019-08-21 2019-08-30 92026
APO-QUINAPRIL/HCTZ 25MG 20MG TABLET Resolved 2019-08-21 2019-09-16 92032
APO-TAMOX TAB 10MG 10MG TABLET Resolved 2019-08-21 2019-12-07 92035
APO-TADALAFIL 5MG TABLET Resolved 2019-08-23 2020-01-22 92387
APO-DEXAMETHASONE 4MG TABLET Resolved 2019-08-28 2020-09-09 92513
APO-ESCITALOPRAM 20MG TABLET Resolved 2019-08-28 2020-02-19 92522
APO-PANTOPRAZOLE 40MG TABLET (DELAYED-RELEASE) Resolved 2019-08-28 2019-12-20 92525
APO-ACETAMINOPHEN CAPLETS EXTRA STRENGTH 500MG TABLET Resolved 2019-09-04 2020-01-07 92962
APO-DILTIAZ CD 240MG CAPSULE (CONTROLLED-DELIVERY) Resolved 2019-09-04 2019-10-15 92965
APO-DIVALPROEX 250MG TABLET (ENTERIC-COATED) Resolved 2019-09-04 2019-10-28 92968
APO-DIVALPROEX 500MG TABLET (ENTERIC-COATED) Resolved 2019-09-04 2019-11-11 92971
APO-EMTRICITABINE-TENOFOVIR 300MG 200MG TABLET Resolved 2019-09-04 2019-09-06 92974
APO-LAMOTRIGINE 25MG TABLET Resolved 2019-09-04 2020-01-29 92978
APO-LANSOPRAZOLE 30MG CAPSULE (DELAYED RELEASE) Resolved 2019-09-04 2019-12-19 92981
APO-OLANZAPINE ODT 15MG TABLET (ORALLY DISINTEGRATING) Resolved 2019-09-04 2019-10-01 92984
APO-PANTOPRAZOLE 40MG TABLET (DELAYED-RELEASE) Resolved 2019-09-04 2019-11-21 92989
APO-TIMOP 0.5% SOLUTION Resolved 2019-09-04 2020-07-29 92992

Showing 1401 to 1420 of 3034

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-GEMFIBROZIL CAP 300MG USP Discontinued 2019-06-12 2019-06-12 86557
IBUPROFEN CAPLETS 200MG TABLET Discontinued 2019-07-12 2019-07-13 89135
APO-DICLO 50MG TABLET (ENTERIC-COATED) Discontinued 2019-08-07 2019-08-07 91117
APO-GLIMEPIRIDE Discontinued 2019-09-20 2019-09-20 94446
APO-GLIMEPIRIDE Discontinued 2019-09-20 2019-09-20 94449
APO-GLIMEPIRIDE Discontinued 2019-09-20 2019-09-20 94452
APO-CLINDAMYCIN 150MG CAPSULE Discontinued 2019-11-11 2019-11-11 98363
APO-HYDROCHLOROTHIAZIDE Discontinued 2019-11-26 2019-11-26 99653
APO-IMIQUIMOD Discontinued 2019-11-26 2019-11-26 99672
APO-DIPYRIDAMOLE 75MG TABLET Discontinued 2019-12-20 2019-12-21 101880
APO-DIPYRIDAMOLE 25MG TABLET Discontinued 2019-12-20 2020-07-30 101888
APO-DIPYRIDAMOLE 50MG TABLET Discontinued 2019-12-20 2020-07-30 101891
APO-CARBAMAZEPINE Discontinued 2020-02-19 2020-02-19 106679
APO-HYDROMORPHONE CR 3MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-04-04 2020-04-04 110956
APO-HYDROMORPHONE CR 6MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-04-04 2020-04-04 110959
APO-HYDROMORPHONE CR 12MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-04-04 2020-04-04 110962
APO-HYDROMORPHONE CR 18MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-04-04 2020-04-04 110965
APO-HYDROMORPHONE CR 24MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-04-04 2020-04-04 110968
APO-HYDROMORPHONE CR 30MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-04-04 2020-04-04 110971
APO-HYDROMORPHONE CR 4.5MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-04-04 2020-04-04 110974

Showing 301 to 320 of 356